EUVIMEDEUVIMED entdecken
Open Access

Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug

Gautam U Mehta iD, Richard Pazdur

Journal of Clinical Oncology · 10.11.2024 · 42 (32) · 3778-3782

DOI: 10.1200/jco-24-01654 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.11.2024. Verfasst von Gautam U Mehta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural FDA HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Food and Drug Administration's (FDA) accelerated approval (AA) program is a regulatory pathway allowing for early approval of drugs based on endpoints that are reasonably likely to predict clinical benefit (Figure 1).The majority (60%) of these approvals have been granted for oncology indications, leading to patient access an estimated median 3.1 years prior to approval through the traditional pathway.After AA, FDA requires successful completion of confirmatory trials to verify clinical benefit, otherwise the AA indication may be withdrawn.These issues have been publicly scrutinized and addressed by recent legislation in the Consolidated Appropriations Act, which allows FDA to require that confirmatory trials are underway at the time of AA and specifies new, streamlined processes for withdrawal of an AA.

Autor:innen und Institutionen

  • Oncology Center of Excellence, Food and Drug Administration, Silver Spring, MD.

ORCID-Profile: Gautam U Mehta

Förderung

  • Intramural FDA HHS

Zitieren

APA

Mehta, G. U., & Pazdur, R. (2024). Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug. Journal of Clinical Oncology, 42(32), 3778-3782. https://doi.org/10.1200/jco-24-01654

Vancouver

Mehta GU, Pazdur R. Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug. Journal of Clinical Oncology. 2024;42(32):3778-3782. doi:10.1200/jco-24-01654

BibTeX
@article{Mehta2024,
  author = {Mehta, Gautam U and Pazdur, Richard},
  title = {Oncology Accelerated Approval Confirmatory Trials: When a Failed Trial Is Not a Failed Drug},
  journal = {Journal of Clinical Oncology},
  year = {2024},
  volume = {42},
  number = {32},
  pages = {3778--3782},
  doi = {10.1200/jco-24-01654}
}
Kostenlos starten →